Renafor-B Inhalation Capsule 200 mcg + 6 mcg is a high-strength dry-powder inhalation therapy that combines Budesonide, an inhaled corticosteroid, and Formoterol Fumarate, a long-acting beta-2 adrenergic agonist (LABA). This combination is designed for the long-term management of moderate to severe asthma and chronic obstructive pulmonary disease (COPD), providing both anti-inflammatory action and sustained bronchodilation.

Budesonide reduces airway inflammation, swelling, and mucus production, addressing the underlying causes of persistent respiratory symptoms. Formoterol Fumarate relaxes bronchial smooth muscles, opening the airways and improving airflow. The 200 mcg dose of Budesonide provides enhanced anti-inflammatory control for patients with more severe or uncontrolled symptoms, while the 6 mcg Formoterol ensures consistent bronchodilation.

Renafor-B Inhalation Capsules are administered via a dry-powder inhaler device, delivering precise doses directly to the lungs. This method ensures rapid onset of action, improved lung function, and long-term symptom control, reducing the frequency of asthma attacks or COPD exacerbations.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Budesonide – 200 mcg

• Formoterol Fumarate – 6 mcg

Mechanism of Action

Renafor-B works through the synergistic action of its components:

• Budesonide: Suppresses airway inflammation by inhibiting inflammatory cells and mediators. It reduces swelling, mucus secretion, and hypersensitivity in the bronchial lining, preventing flare-ups.

• Formoterol Fumarate: Activates beta-2 adrenergic receptors in airway smooth muscles, causing long-lasting bronchodilation, improving airflow, and relieving symptoms like wheezing and shortness of breath.

The combination ensures both long-term prevention of exacerbations and effective maintenance of airway function.

Indications

Renafor-B Inhalation Capsule 200/6 mcg is indicated for:

• Moderate to severe persistent asthma requiring high-strength inhaled corticosteroid therapy

• Chronic Obstructive Pulmonary Disease (COPD) with persistent symptoms

• Prevention of asthma or COPD exacerbations in patients inadequately controlled with lower doses

• Long-term maintenance therapy for airway inflammation and obstruction

It is intended for maintenance therapy and not suitable as a rescue inhaler for sudden attacks.

Dosage and Administration

Dosage should be individualized based on the patient’s condition and physician’s recommendation:

• Typical dose: 1 capsule inhaled twice daily, or as prescribed

• Place the capsule in the dry-powder inhaler device

• Exhale fully, place the mouthpiece in the mouth, and inhale deeply to ensure the medication reaches the lungs

• Hold the breath for 5–10 seconds before exhaling

• Do not swallow the capsule; it is for inhalation only

• Rinse the mouth after inhalation to reduce the risk of oral thrush

Consistent daily use is essential for effective long-term control.

Possible Side Effects

Common side effects include:

• Throat irritation or hoarseness

• Cough

• Dry mouth

• Tremors or palpitations

• Headache

Less common but serious side effects may include:

• Severe allergic reactions

• Worsening of respiratory symptoms

• Increased heart rate or arrhythmias

Patients should contact their healthcare provider if severe or persistent symptoms occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Inform your doctor of heart disease, high blood pressure, thyroid disorders, or seizures

• Regular monitoring of lung function may be necessary

• Not suitable as a rescue inhaler; a short-acting bronchodilator should be available for sudden symptoms

• Use during pregnancy or breastfeeding only under medical supervision

Storage

• Store below 30°C in a dry place

• Keep capsules in the blister pack until ready to use

• Protect from moisture and direct sunlight

• Keep out of reach of children

Conclusion

Renafor-B Inhalation Capsule 200 mcg + 6 mcg (Budesonide + Formoterol Fumarate) is a high-strength dry-powder therapy for long-term management of moderate to severe asthma and COPD. By combining potent anti-inflammatory effects with sustained bronchodilation, it helps prevent exacerbations, improve airflow, and maintain optimal lung function. Proper use under medical supervision ensures safe, effective, and consistent control of chronic respiratory conditions.